arrow
T

Thomas A. Mace

The Ohio State University
H指数:34
被引数:4,232

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Fc gamma receptor binding modulates IgG clearance in cancer cachexia

Fcγ受体结合调节癌症恶病质中IgG的清除

2026-03-310
OAAI
A Novel Mouse Model to Identify Antigen-Specific Immune Responses in Pancreatic Cancer Cachexia

一种新型小鼠模型,用于识别胰腺癌恶病质中的抗原特异性免疫应答

Cancers
IF4.4
2026-02-110
OAAI
Clinical risk factors for sarcopenia in acute and chronic pancreatitis

急性与慢性胰腺炎肌减少症的临床危险因素

2025-02-060
OA
Physical Activity Decreases Inflammation and Delays the Development of Obesity-Associated Pancreatic Ductal Adenocarcinoma

体力活动减少炎症并延缓肥胖相关胰腺导管腺癌的发展

2024-05-222
PRE
Systemic Neutrophil Gelatinase-Associated Lipocalin Alterations in Chronic Pancreatitis: A Multicenter, Cross-Sectional Study
2024-01-261
OAAI
Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexia
2024-01-011
OAAI
Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell- and CXCR3-dependent manner
2023-04-2414
OAAI
Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy

血清白蛋白: 免疫检查点抑制剂单药治疗而非化学免疫治疗获益的早期预后指标

2022-06-0121
OAAI
Analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients pre- and post-neoadjuvant chemotherapy for operable breast cancer
2020-08-150
PRE
Suppressive myeloid cells are expanded by biliary tract cancer-derived cytokines in vitro and associate with aggressive disease
2020-08-046
OAAI
Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer
2020-05-1914
OAAI
Disruption of stromal hedgehog signaling initiates RNF5-mediated proteasomal degradation of PTEN and accelerates pancreatic tumor growth

基质hedgehog信号的破坏启动PTEN的RNF5-mediated蛋白酶体降解并加速胰腺肿瘤的生长

2018-10-2632
OA
Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment
2017-05-14119
OAAI